Literature DB >> 15886230

Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.

Katarina Trebusak Podkrajsek1, Nina Bratanic, Ciril Krzisnik, Tadej Battelino.   

Abstract

CONTEXT: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive disease associated with mutations in the AIRE gene.
OBJECTIVE: Our objective was to investigate clinical and mutational characteristics of 12 Slovenian patients from 10 families with APECED.
METHODS: Direct sequencing, restriction fragment length polymorphism, and amplification refractory mutation system analyses were used to identify AIRE gene mutations. Autoimmune regulator (AIRE)-1 mRNA analysis was used to confirm pathogenicity of the intronic mutation.
RESULTS: The prevalence of APECED in Slovenian population was estimated to be 1 in 43,000, which is significantly higher compared with the neighboring populations. Three novel mutations were identified among six different mutations detected in the AIRE gene. The first novel mutation was an intronic mutation (653-7_-5delCTC) affecting proper splicing by using a nearby new acceptor splice site as demonstrated by AIRE-1 mRNA analyses. The second and third novel mutations were frame-shift mutations located in exon 5 (540delG) and exon 9 (1064-1068dupCCCGG), both leading to premature truncation of the AIRE protein. The Finnish R257X mutation was the most frequent AIRE gene mutation in Slovenian patients with APECED (16 of 24 alleles).
CONCLUSIONS: Three novel AIRE gene mutations were identified. For the first time, a novel intronic mutation was investigated on the mRNA level in APECED. This could be particularly important for APECED patients where no or only heterozygous mutation on the genomic DNA level is detected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886230     DOI: 10.1210/jc.2005-0418

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

Authors:  Elise M N Ferré; Timothy J Break; Peter D Burbelo; Michael Allgäuer; David E Kleiner; Dakai Jin; Ziyue Xu; Les R Folio; Daniel J Mollura; Muthulekha Swamydas; Wenjuan Gu; Sally Hunsberger; Chyi-Chia R Lee; Anamaria Bondici; Kevin W Hoffman; Jean K Lim; Kerry Dobbs; Julie E Niemela; Thomas A Fleisher; Amy P Hsu; Laquita N Snow; Dirk N Darnell; Samar Ojaimi; Megan A Cooper; Martin Bozzola; Gary I Kleiner; Juan C Martinez; Robin R Deterding; Douglas B Kuhns; Theo Heller; Karen K Winer; Arun Rajan; Steven M Holland; Luigi D Notarangelo; Kevin P Fennelly; Kenneth N Olivier; Michail S Lionakis
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 17.956

Review 2.  Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Gregory M Constantine; Michail S Lionakis
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Choudhary Sonal; McLeod Michael; Torchia Daniele; Romanelli Paolo
Journal:  J Clin Aesthet Dermatol       Date:  2012-12

4.  Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Elise M N Ferre; Stacey R Rose; Sergio D Rosenzweig; Peter D Burbelo; Kimberly R Romito; Julie E Niemela; Lindsey B Rosen; Timothy J Break; Wenjuan Gu; Sally Hunsberger; Sarah K Browne; Amy P Hsu; Shakuntala Rampertaap; Muthulekha Swamydas; Amanda L Collar; Heidi H Kong; Chyi-Chia Richard Lee; David Chascsa; Thomas Simcox; Angela Pham; Anamaria Bondici; Mukil Natarajan; Joseph Monsale; David E Kleiner; Martha Quezado; Ilias Alevizos; Niki M Moutsopoulos; Lynne Yockey; Cathleen Frein; Ariane Soldatos; Katherine R Calvo; Jennifer Adjemian; Morgan N Similuk; David M Lang; Kelly D Stone; Gulbu Uzel; Jeffrey B Kopp; Rachel J Bishop; Steven M Holland; Kenneth N Olivier; Thomas A Fleisher; Theo Heller; Karen K Winer; Michail S Lionakis
Journal:  JCI Insight       Date:  2016-08-18

Review 5.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

Authors:  Kai Kisand; Pärt Peterson
Journal:  J Clin Immunol       Date:  2015-07-05       Impact factor: 8.317

6.  Genetic analysis of adult Slovenian patients with combined pituitary hormone deficiency.

Authors:  Katica Bajuk Studen; Magdalena Avbelj Stefanija; Alexandru Saveanu; Anne Barlier; Thierry Brue; Marija Pfeifer
Journal:  Endocrine       Date:  2019-05-15       Impact factor: 3.633

7.  Molecular background and genotype-phenotype correlation in autoimmune-polyendocrinopathy-candidiasis-ectodermal-distrophy patients from Campania and in their relatives.

Authors:  D Capalbo; C Mazza; R Giordano; N Improda; E Arvat; S Cervato; L Morlin; C Pignata; C Betterle; M Salerno
Journal:  J Endocrinol Invest       Date:  2011-04-20       Impact factor: 4.256

8.  French-Canadian families from Saguenay-Lac-Saint-Jean: a new founder population for APECED.

Authors:  Tania Cruz Marino; Hélène Villeneuve; Josianne Leblanc; Caroline Duranceau; Philippe Caron; Charles Morin; Marcel Milot; Raphaëlle Chrétien; Maude-Marie Gagnon; Jean Mathieu; Benjamin Ellezam; Daniela Buhas
Journal:  Endocrine       Date:  2021-11-30       Impact factor: 3.633

9.  Evolutionarily conserved and divergent regions of the autoimmune regulator (Aire) gene: a comparative analysis.

Authors:  Mark Saltis; Michael F Criscitiello; Yuko Ohta; Matthew Keefe; Nikolaus S Trede; Ryo Goitsuka; Martin F Flajnik
Journal:  Immunogenetics       Date:  2008-01-23       Impact factor: 2.846

Review 10.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective.

Authors:  D Capalbo; N Improda; A Esposito; L De Martino; F Barbieri; C Betterle; C Pignata; M Salerno
Journal:  J Endocrinol Invest       Date:  2013-05-30       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.